Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2026-04-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
董事会对独立董事独立性评估的专项意见
Governance Information Classification · 95% confidence The document is a statement from the board of directors assessing the independence of the company's independent directors, referencing regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules. It is a formal opinion on governance matters, specifically about the independence of board members, rather than financial data, voting results, or other report types. The content aligns with governance-related disclosures rather than financial reports or announcements. Therefore, the document fits best under Governance Information (CGR). The document length is short and focused on governance compliance, not a report publication or regulatory filing.
2026-04-28 Chinese
2025年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' (Audit Report) and contains detailed auditor opinions, audit basis, key audit matters, management responsibilities, and auditor responsibilities. It includes extensive discussion of financial statement auditing procedures, accounting policies, and financial data for the fiscal year ending December 31, 2025. The presence of an independent auditor's opinion and detailed audit procedures confirms this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), indicating it is the full audit report, not just an announcement or certification. Therefore, the document fits the category of Audit Report / Information (AR).
2026-04-28 Chinese
独立董事2025年度述职报告-胡诗阳
Board/Management Information Classification · 95% confidence The document is an Independent Director's 2025 Annual Work Report for Chengdu Berry Genomics Co., Ltd. It details the independent director's duties, attendance at board and shareholder meetings, committee work, communication with auditors, and oversight of financial and governance matters during the year 2025. The content focuses on governance, compliance, audit committee activities, and the director's professional opinions on company operations and financial reporting. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a brief announcement or certification. It is a detailed management/governance-related report by a board member about their annual duties and oversight. This fits best under Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities. The document is about the independent director's annual report on their duties, not a financial report or audit report itself.
2026-04-28 Chinese
内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It is issued by an accounting firm and addresses the effectiveness of the company's internal control over financial reporting as of December 31, 2025. The content includes auditor responsibilities, company responsibilities, and an audit opinion on internal control effectiveness. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document is not a full annual report, nor is it a brief announcement or certification. Therefore, the appropriate classification is AR with high confidence.
2026-04-28 Chinese
关于2025年度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the provision for asset impairment for the fiscal year 2025. It details the amounts of impairment provisions, the accounting policies applied, and the impact on financial results. The document includes board and audit committee opinions on the reasonableness of the impairment provision. The length is about 2353 characters, which is relatively short and the document is an announcement of a specific accounting action rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis typical of an Annual Report (10-K) or Interim Report (IR). It is not a certification or regulatory compliance filing. The content is focused on the impairment provision announcement, which is a specific financial update but not a full earnings release or capital update. Given the nature and length, this fits best under Regulatory Filings (RNS) as a general regulatory announcement about accounting provisions and board approvals, rather than a full report or other specific category.
2026-04-28 Chinese
第十届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 21st meeting of the 10th Board of Directors of the company, including approval of the 2025 Annual Report, profit distribution plan, appointment of auditors, internal control evaluation, and other governance matters. It references the 2025 Annual Report and other reports but does not contain the full reports themselves. The document is relatively short (3535 characters) and repeatedly states that full reports and details are published on an external website (cninfo.com.cn). This indicates it is a formal announcement of board meeting decisions and related governance matters rather than the full annual report or financial statements. The content aligns with a Board/Management Information filing, as it announces board meeting resolutions and management reports for shareholder consideration. Therefore, the appropriate classification is MANG (Board/Management Information).
2026-04-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.